GB1384887A - Sustained release pharmaceutical tablet - Google Patents
Sustained release pharmaceutical tabletInfo
- Publication number
- GB1384887A GB1384887A GB4133771A GB4133771A GB1384887A GB 1384887 A GB1384887 A GB 1384887A GB 4133771 A GB4133771 A GB 4133771A GB 4133771 A GB4133771 A GB 4133771A GB 1384887 A GB1384887 A GB 1384887A
- Authority
- GB
- United Kingdom
- Prior art keywords
- sustained release
- medicament
- soluble
- copolymers
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000013268 sustained release Methods 0.000 title abstract 2
- 239000012730 sustained-release form Substances 0.000 title abstract 2
- 239000003814 drug Substances 0.000 abstract 4
- 229920001577 copolymer Polymers 0.000 abstract 3
- 239000011347 resin Substances 0.000 abstract 3
- 229920005989 resin Polymers 0.000 abstract 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 abstract 2
- 210000004051 gastric juice Anatomy 0.000 abstract 2
- 239000011256 inorganic filler Substances 0.000 abstract 2
- 229910003475 inorganic filler Inorganic materials 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- DBGIVFWFUFKIQN-UHFFFAOYSA-N (+-)-Fenfluramine Chemical compound CCNC(C)CC1=CC=CC(C(F)(F)F)=C1 DBGIVFWFUFKIQN-UHFFFAOYSA-N 0.000 abstract 1
- GAMPNQJDUFQVQO-UHFFFAOYSA-N acetic acid;phthalic acid Chemical compound CC(O)=O.OC(=O)C1=CC=CC=C1C(O)=O GAMPNQJDUFQVQO-UHFFFAOYSA-N 0.000 abstract 1
- 229920002678 cellulose Polymers 0.000 abstract 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 abstract 1
- XZTWHWHGBBCSMX-UHFFFAOYSA-J dimagnesium;phosphonato phosphate Chemical compound [Mg+2].[Mg+2].[O-]P([O-])(=O)OP([O-])([O-])=O XZTWHWHGBBCSMX-UHFFFAOYSA-J 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 229960002179 ephedrine Drugs 0.000 abstract 1
- 239000000945 filler Substances 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- TTWJBBZEZQICBI-UHFFFAOYSA-N metoclopramide Chemical compound CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC TTWJBBZEZQICBI-UHFFFAOYSA-N 0.000 abstract 1
- 229960004503 metoclopramide Drugs 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- WRLGYAWRGXKSKG-UHFFFAOYSA-M phenobarbital sodium Chemical compound [Na+].C=1C=CC=CC=1C1(CC)C(=O)NC([O-])=NC1=O WRLGYAWRGXKSKG-UHFFFAOYSA-M 0.000 abstract 1
- 229920002689 polyvinyl acetate Polymers 0.000 abstract 1
- 239000011118 polyvinyl acetate Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 abstract 1
- 229960004618 prednisone Drugs 0.000 abstract 1
- 239000002002 slurry Substances 0.000 abstract 1
- 239000007939 sustained release tablet Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BE787973D BE787973A (fr) | 1971-09-04 | Comprimes pharmaceutiques a effet retard | |
| GB4133771A GB1384887A (en) | 1971-09-04 | 1971-09-04 | Sustained release pharmaceutical tablet |
| ZA725506A ZA725506B (en) | 1971-09-04 | 1972-08-10 | Sustained release pharmaceutical tablet |
| FR7230623A FR2150931B1 (enrdf_load_stackoverflow) | 1971-09-04 | 1972-08-29 | |
| JP8828372A JPS561288B2 (enrdf_load_stackoverflow) | 1971-09-04 | 1972-09-02 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4133771A GB1384887A (en) | 1971-09-04 | 1971-09-04 | Sustained release pharmaceutical tablet |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1384887A true GB1384887A (en) | 1975-02-26 |
Family
ID=10419222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB4133771A Expired GB1384887A (en) | 1971-09-04 | 1971-09-04 | Sustained release pharmaceutical tablet |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JPS561288B2 (enrdf_load_stackoverflow) |
| BE (1) | BE787973A (enrdf_load_stackoverflow) |
| FR (1) | FR2150931B1 (enrdf_load_stackoverflow) |
| GB (1) | GB1384887A (enrdf_load_stackoverflow) |
| ZA (1) | ZA725506B (enrdf_load_stackoverflow) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4917900A (en) * | 1987-03-27 | 1990-04-17 | Burroughs Wellcome Co. | Controlled release formulations containing zidovudine |
| EP1207852A4 (en) * | 1999-09-02 | 2009-11-11 | Nostrum Pharmaceuticals Inc | ORAL PHARMACEUTICALS WITH TAXED RELEASE FOR ORAL ADMINISTRATION |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5541976A (en) * | 1978-09-20 | 1980-03-25 | Mazda Motor Corp | Supply system for neutralizing agent at electrodeposition coating |
| JPS5597498A (en) * | 1979-01-19 | 1980-07-24 | Mazda Motor Corp | Dipping and water washing system for electrodeposition coating |
| EP0022117A3 (fr) * | 1979-06-08 | 1981-11-11 | Ady Trenker | Résinate de metoclopramide et médicament le contenant |
| FR2492661A1 (fr) * | 1980-10-28 | 1982-04-30 | Laruelle Claude | Nouvelle forme galenique d'administration du metoclopramide, son procede de preparation et medicament comprenant cette nouvelle forme |
| JPH0776172B2 (ja) * | 1986-04-16 | 1995-08-16 | 藤沢薬品工業株式会社 | マトリツクス錠 |
-
0
- BE BE787973D patent/BE787973A/xx not_active IP Right Cessation
-
1971
- 1971-09-04 GB GB4133771A patent/GB1384887A/en not_active Expired
-
1972
- 1972-08-10 ZA ZA725506A patent/ZA725506B/xx unknown
- 1972-08-29 FR FR7230623A patent/FR2150931B1/fr not_active Expired
- 1972-09-02 JP JP8828372A patent/JPS561288B2/ja not_active Expired
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4917900A (en) * | 1987-03-27 | 1990-04-17 | Burroughs Wellcome Co. | Controlled release formulations containing zidovudine |
| EP1207852A4 (en) * | 1999-09-02 | 2009-11-11 | Nostrum Pharmaceuticals Inc | ORAL PHARMACEUTICALS WITH TAXED RELEASE FOR ORAL ADMINISTRATION |
Also Published As
| Publication number | Publication date |
|---|---|
| BE787973A (fr) | 1973-02-26 |
| JPS4833017A (enrdf_load_stackoverflow) | 1973-05-07 |
| FR2150931A1 (enrdf_load_stackoverflow) | 1973-04-13 |
| ZA725506B (en) | 1973-04-25 |
| JPS561288B2 (enrdf_load_stackoverflow) | 1981-01-13 |
| FR2150931B1 (enrdf_load_stackoverflow) | 1975-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4983398A (en) | Sustained release drug dosage forms containing hydroxypropylmethylcellulose and alkali metal carboxylates | |
| US3773920A (en) | Sustained release medicinal composition | |
| Brade et al. | Ifosfamide-pharmacology, safety and therapeutic potential | |
| US3074852A (en) | Pharmaceuticals with delayed release | |
| US3131123A (en) | Enteric tablets and manufacture thereof | |
| EP0011489B1 (en) | An analgesic effervescent powder and process for its preparation | |
| IL42232A (en) | Dry medicines for oral administration | |
| GB1359643A (en) | Controlled release medicament | |
| JPH07509479A (ja) | 長期間にわたって２段階で放出する形態を有する固体の薬剤投与形態およびその製造 | |
| MY104898A (en) | Modified release gemfibrozil composition | |
| GB2176704A (en) | Solid, stable dosage forms with an elastic film coating | |
| RO114737B1 (ro) | Preparat farmaceutic oral | |
| US3632778A (en) | Tablets containing l-dopa | |
| US3101299A (en) | Silica-gel powder tablet compositions | |
| GB1384887A (en) | Sustained release pharmaceutical tablet | |
| GB1287431A (en) | Improvements in pharmaceutical formulations | |
| GB1506345A (en) | Multitioned tablets | |
| US3437728A (en) | Protracted release pharmaceutical compositions | |
| FR2108032A1 (en) | Prolonged progressively released oral medicament - comprises a solid excipient and cellulose dicarboxylic acid binder | |
| JP4774739B2 (ja) | 漢方エキス含有錠剤組成物およびその製造方法 | |
| CA1229552A (en) | Cimetidine compositions | |
| US3524917A (en) | Tablets of magnesium probenecid tetrahydrate | |
| ES387532A1 (es) | Procedimiento para fabricar un medicamento. | |
| US3784708A (en) | Directly compressible monocalcium phosphate | |
| JPS5344617A (en) | Drug composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PCNP | Patent ceased through non-payment of renewal fee |